Fed Officials Leave Door Open to Adjustments, Driving Rebalancing Across Fragmented EquitiesGlobal Report·1 day ago, 04:13 AMEQIX-2.90%DUO+1.48%
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquiredrttnews·1 day ago, 10:34 PMFBRX-0.12%TVGNW0.00%
Omeros repurchases USD 14.5 million of 9.5% convertible notes due 2029 for USD 29 millionPUBT·Jul 20 at 04:05 PMOMER+1.86%
10:31 ETComplement 3 Glomerulopathy Market Set for Transformation: 4 Emerging Therapies Leading the Next Growth Phase | DelveInsightprnewswire·Jul 16 at 09:31 AMKPRX-1.17%ARWR-1.00%
19:57 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMERprnewswire·Jul 9 at 07:05 PMOMER+1.86%
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law FirmMorningStar·Jul 6 at 07:12 PMOMER+1.86%
Omeros expects to complete repurchase of $16 million of 9.5% convertible notes due 2029 for about $31.3 millionPUBT·Jul 6 at 07:32 AMOMER+1.86%
20:11 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMERprnewswire·Jul 1 at 07:12 PMOMER+1.86%
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Sessionbenzinga_article·Jun 29 at 07:11 AMGT-1.43%TOST+1.58%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Jun 26 at 12:05 PMCELZ-3.86%CRIS+3.52%
Buy Rating Maintained on YARTEMLEA as Analyst Trims Price Target to $33 but Sees U.S. Launch Driving UpsideTip Ranks·Jun 26 at 10:35 AMOMER+1.86%
